There is no exact data on the cure rate of T3N0M0 radical surgery for intermediate-term lung adenocarcinoma. 5-year survival rate is commonly used to assess the efficacy of tumor treatment, and the 5-year survival rate is about 50%.
T3N0M0 is based on the size of primary tumor, lymph node metastasis and distant metastasis using TNM staging of lung cancer, T3N0M0 represents that the lung adenocarcinoma has developed to stage IIB, and the current 5-year survival rate is about 50%. Surgical resection for radical treatment and adjuvant radiotherapy can significantly improve the 5-year survival rate.
It is recommended that patients follow the doctor’s instructions to standardize the treatment, and may carry out the appropriate postoperative adjuvant treatment strategy according to the individual situation.